BTEC
Principal Healthcare Innovators ETF
Russell 2000 Ind/HC TR USD
NAV as of
4 Week: 31.99 - 35.94
52 Week: 27.71 - 41.43
Latest Closing Price
33.13
Premium / Discount
0.05
Expense Ratio
0.42%
Investment Objective
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -2.88 | 1.73 | -1.67 |
| 1 Day | -1.42 | 0.00 | 0.00 |
| 1 Week | 1.80 | 3.23 | 0.56 |
| 1 Month | -6.58 | 8.94 | -0.74 |
| 3 Months | -2.88 | 13.70 | -0.21 |
| 6 Months | -4.98 | 22.20 | -0.22 |
| 1 Year | -18.51 | 38.46 | -0.48 |
| 2 Years | -41.10 | 49.89 | -0.82 |
| 3 Years | 2.87 | 60.04 | 0.05 |
| 5 Years | 0.18 | 74.67 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 36.2654 | -11.2012 | 38.9183 | 52.5240 | -18.4398 | -28.8368 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 13.0000 | 90.0000 | 6.0000 | 9.0000 | 95.0000 | 85.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 28/12/2021 | 02/01/2022 | 0.4532 |
| 16/12/2020 | 21/12/2020 | 0.2154 |
| 14/12/2017 | 19/12/2017 | 0.0415 |
Portfolio Data
Total Number of Holdings: 248
Number of Bond Holdings: 0
Number of Equity Holdings: 245
Total Market Value: 51,865,016
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Moderna Inc | 4.8242 | 60,736 | 2,617 | 7,953,379 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 0.00 |
| Large | 0.00 |
| Medium | 25.96 |
| Small | 38.84 |
| Micro | 35.01 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
21.7214
Price/Book*
3.3746
Price/Sales*
4.3831
Price/Cash Flow*
10.7579
Dividend Yield*
0.0427
Growth Measures
Long-Term Earnings
20.2149
Historical Earnings
41.9556
Sales Growth
8.0317
Cash-Flow Growth
-17.1468
Book-Value Growth
-3.8743
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
